Association between IL4 (-590), ACE (I)/(D), CCR5 (δ32), CTLA4 (+49) and ILl-RN (VNTR in intron 2) gene polymorphisms and vitiligo

European Journal of Dermatology

Volumn 19, Issue 2, 2009, Pages 126-128

  Sacide Pehlivan, ^a   Ozkinay, Ferda ^b   Alper, Sibel ^b   Onay, Huseyin ^b   Yuksel, Eda ^b   Pehlivan, Mustafa ^a   Ozkinay, Cihangir ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

ACE; CCR5; CTLA4; IL4; ILl RN; Polymorphisms; Vitiligo

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; LEUKOCYTE ANTIGEN;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; INTRON; POLYMERASE CHAIN REACTION; POPULATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC); VITILIGO; AGAR GEL ELECTROPHORESIS; ALLELE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION;

ALLELES; ANTIGENS, CD; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ELECTROPHORESIS, AGAR GEL; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-4; INTRONS; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; TURKEY; VITILIGO;

EID: 65449129666     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2008.0578     Document Type: Article

References (23)

1. Sehgal VN, Srivastava G. Vitiligo: compendium of clinico features. Indian J Dermatol Venéreo! Leprol 2007;73: 149-56.
2. Tamer E, llhan MN, Polat M, et al. Prevalence of skin diseases pediatric patients in Turkey. JDermatol 2008; 35: 413-8.
3. Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and autoimmune diseases in causian proband and their fami . Pigment Cell Res 2003; 16: 208-14.
4. Gauthier Y, Cario AM, Taieb A. A critical apraisal of vitiligo etilo theories. Is melonocyte loss a melanocytorrhagy? Pigment Cell Xes2003; 16: 322-32.
5. Schwarz T. Dermatology and basic science. Eur J Dermatol 2007; 17: 182-4.
6. Jin SY, Park HH, Li GZ, et al. Association of Angioensin Convert Enzyme Gene l/D Polymorphism of Vitiligo in Korean Polymor . Pigment Cell Res 2004; 17: 84-6.
7. Lee CS, Lee YJ, Liu HF, et al. Association o the CTLA4 gene A-G wth reumotoid artritis in Chinese. Clin Reumotol 2003;000: 2214.
8. Kristiansen OP, Larsen ZM, Poicot F. CTLA-4 in autoimmune a general susceptibility gene to autoimmunity? Genes 2000; 1: 170-84.
9. Scarel-Caminaga RM, Trevilatto PC, Souza AP, et al. Investigation IL4 gene polymorphism in individuals with different levels of periodontitis in a Brazilian population. J Clin Periodontal 2003; 30: 341-5.
10. Viet HT, Wagsater D, Hugander A, et al. Interleukin-l receptor gene polymorphism in human colorectal cancer. Oncol 2005; 14:915-8.
11. Karam W, Jurjus R, Khoury N, ef ai. Frequency of the CCR5-delta chemokine receptor gene mutation in the Lebanase population. East Mediterr Health J 2004; 10: 671-5.
12. Onay H, Pehlivan M, Alper S, et al. Might there be a link mannose binding lectin and vitiligo? Eur J Dermatol 2007;000: 146-8.
13. Kemp EH, Ayan RA, Waterman EA, et al. Analysis of a microsat polymorphism of the CTLA4 gene in patients with vitiligo. Br Dermatol 1999; 140:73-8.
14. Kristensen D, Bradley CA, Hao M. Case/control association of candidate genes for vitiligo susceptibility: tyrosine metabo and immune response genes. Clin Chem 2000; 46: 811.
15. Rosenwasser U, Klemm DJ, Dresback JK, et al. Promoter poly in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 25: 74.
16. Prahalad S. Negative association between the chemokine recep CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta . Genes Immun 2006; 7: 264-8.
17. Otaegui D, Ruiz-Martinez J, Olaskoaga J, et al. Influence of Delta 32 genotype in Spanish population with multiple sclero . Neurogenetics 2Ó07; 8: 201-5.
18. Huang CM, VVuMC, WuJY, et al. Interleukin-l receptor antago gene polymorphism in Chinese patients with systemic lupus. Clin Rheumatol 2002; 21: 255-7.
19. DAlfonso S, Rampi M, Bocchio D, et al. Systemic lupus erythe candidate genes in the Italian population: evidence for a sig association with interleukin-l0. Arthritis Rheum 2000; 43:120-8.
20. You CG, Li JF, Xie XD, et al. Association of interleukin-l genetic with the risk of rheumatoid arthritis in Chinese popula . Clin Chem Lab Med 2007; 45: 968-71.
21. Akhtar S, Gavalas NG, Gawkrodger DJ, et al. An insertion/dele polymorphism in the gene encoding angiotensin converting is not associated with generalized vitiligo in an English pop . Arch Dermatol Res 2005; 297: 94-8.
22. Dwivedi M, Laddha NC, Shajil EM, et al. The ACE gene I/ D is not associated with generalized vitiligo susceptibility Gujarat population. Pigment Cell Melanoma Res 2008; 21: 407-8.
23. Itirli G, Pehlivan M, Alper S, et al. Exon-3 polymorphism of CTLA gene in Turkish patients with vitiligo. JDermatol Sei 2005; 38:000-7.